Cellular and Molecular Neurobiology

, Volume 36, Issue 5, pp 689–700 | Cite as

Deferoxamine Preconditioning of Neural-Like Cells Derived from Human Wharton’s Jelly Mesenchymal Stem Cells as a Strategy to Promote Their Tolerance and Therapeutic Potential: An In Vitro Study

  • Fatemeh Nouri
  • Parvin Salehinejad
  • Seyed Noureddin Nematollahi-mahani
  • Tunku Kamarul
  • Mohammad Reza Zarrindast
  • Ali Mohammad SharifiEmail author
Original Research


Transplantation of neural-like cells is considered as a promising therapeutic strategy developed for neurodegenerative disease in particular for ischemic stroke. Since cell survival is a major concern following cell implantation, a number of studies have underlined the protective effects of preconditioning with hypoxia or hypoxia mimetic pharmacological agents such as deferoxamine (DFO), induced by activation of hypoxia inducible factor-1 (HIF-1) and its target genes. The present study has investigated the effects of DFO preconditioning on some factors involved in cell survival, angiogenesis, and neurogenesis of neural-like cells derived from human Wharton’s jelly mesenchymal stem cells (HWJ-MSCs) in presence of hydrogen peroxide (H2O2). HWJ-MSCs were differentiated toward neural-like cells for 14 days and neural cell markers were identified using immunocytochemistry. HWJ-MSC-derived neural-like cells were then treated with 100 µM DFO, as a known hypoxia mimetic agent for 48 h. mRNA and protein expression of HIF-1 target genes including brain-derived neurotrophic factors (BDNF) and vascular endothelial growth factor (VEGF) significantly increased using RT-PCR and Western blotting which were reversed by HIF-1α inhibitor, while, gene expression of Akt-1, Bcl-2, and Bax did not change significantly but pAkt-1 was up-regulated as compared to poor DFO group. However, addition of H2O2 to DFO-treated cells resulted in higher resistance to H2O2-induced cell death. Western blotting analysis also showed significant up-regulation of HIF-1α, BDNF, VEGF, and pAkt-1, and decrease of Bax/Bcl-2 ratio as compared to poor DFO. These results may suggest that DFO preconditioning of HWJ-MSC-derived neural-like cells improves their tolerance and therapeutic potential and might be considered as a valuable strategy to improve cell therapy.


Deferoxamine Neural-like cells Preconditioning BDNF VEGF 



The authors especially thank S. Tavakol from Department of pharmacology, Iran University of Medical sciences, Tehran, Iran and F. Pour Seyedi, Department of Anatomy, Kerman University of Medical science, Kerman, Iran for valuable assistance. This work was financially supported by Iran University of Medical Sciences and HIR grant from University of Malaya.

Supplementary material

10571_2015_249_MOESM1_ESM.tif (3.1 mb)
Supplementary material 1 (TIFF 3171 kb)
10571_2015_249_MOESM2_ESM.doc (40 kb)
Supplementary material 2 (DOC 40 kb)


  1. Abdel-Salam OM (2011) Stem cell therapy for Alzheimer’s disease. CNS Neurol Disord 10(4):459–485CrossRefGoogle Scholar
  2. Almeida RD, Manadas BJ, Melo CV, Gomes JR, Mendes CS, Grãos MM, Carvalho RF, Carvalho AP, Duarte CB (2005) Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ 12(10):1329–1343CrossRefPubMedGoogle Scholar
  3. Amer J, Dana M, Fibach E (2010) The antioxidant effect of erythropoietin on thalassemic blood cells. Anemia. doi: 10.1155/2010/978710 PubMedPubMedCentralGoogle Scholar
  4. Bliss T, Guzman R, Daadi M, Steinberg G (2007) Stem cells and stroke recovery: introduction cell transplantation therapy for stroke. Stroke 38:817–826CrossRefPubMedGoogle Scholar
  5. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefPubMedGoogle Scholar
  6. Brar VS, Sharma R, Murthy RK, Chalam KV (2010) Bevacizumab neutralizes the protective effect of vascular endothelial growth factor on retinal ganglion cells. Mol Vis 16:1848–1853PubMedPubMedCentralGoogle Scholar
  7. Byts N, Sirén AL (2009) Erythropoietin: a multimodal neuroprotective agent. Exp Transl Stroke Med 1:4CrossRefPubMedPubMedCentralGoogle Scholar
  8. Chen W, Jadhav V, Tang J, Zhang JH (2008a) HIF-1 alpha inhibition ameliorates neonatal brain damage after hypoxic-ischemic injury. Acta Neurochir Suppl 102:395–399CrossRefPubMedGoogle Scholar
  9. Chen W, Jadhav V, Tang J, Zhang JH (2008b) HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model. Neurobiol Dis 31(3):433–441CrossRefPubMedPubMedCentralGoogle Scholar
  10. Chen A, Xiong LJ, Tong Y, Mao M (2013a) The neuroprotective roles of BDNF in hypoxic ischemic brain injury (Review). Biomed Rep 1(2):167–176PubMedGoogle Scholar
  11. Chen A, Xiong LJ, Tong Y, Mao M (2013b) Neuroprotective effect of brain-derived neurotrophic factor mediated by autophagy through the PI3 K/Akt/mTOR pathway. Mol Med Rep 8(4):1011–1016PubMedGoogle Scholar
  12. Eslami H, Sharifi AM, Rahimi H, Rahati M (2014) Protective effect of telmisartan against oxidative damage induced by high glucose in neuronal PC12 cell. Neurosci Lett. doi: 10.1016/j.neulet.2013.10.057 PubMedGoogle Scholar
  13. Gerber HP, Dixit V, Ferrara N (1998a) Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273(21):13313–13316CrossRefPubMedGoogle Scholar
  14. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N (1998b) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3-kinase/Akt signal transduction pathway requirement for Flk-1/KDR activation. J Biol Chem 273(46):30336–30343CrossRefPubMedGoogle Scholar
  15. Gorres KL, Raines RT (2010) Prolyl 4-hydroxylase. Crit Rev Biochem Mol Biol 45(2):106–124CrossRefPubMedPubMedCentralGoogle Scholar
  16. Helan M, Aravamudan B, Hartman WR, Thompson MA, Johnson BD, Pabelick CM, Prakash YS (2014) BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia. J Mol Cell Cardiol 68:89–97CrossRefPubMedPubMedCentralGoogle Scholar
  17. Helton R, Cui J, Scheel JR, Ellison JA, Ames C, Gibson C, Blouw B, Ouyang L, Dragatsis I, Zeitlin S, Johnson RS, Lipton SA, Barlow C (2005) Brain-specific knock-out of hypoxia-inducible factor-1 reduces rather than increases hypoxic-ischemic damage. J Neurosci 25(16):4099–4107CrossRefPubMedGoogle Scholar
  18. Hirota K, Semenza GL (2006) Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 59(1):15–26CrossRefPubMedGoogle Scholar
  19. Kannan K, Jain SK (2000) Oxidative stress and apoptosis. Pathophysiology 7(3):153–163CrossRefPubMedGoogle Scholar
  20. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680–685CrossRefPubMedGoogle Scholar
  21. Lalier L, Cartron PF, Juin P, Nedelkina S, Manon S, Bechinger B, Vallette FM (2007) Bax activation and mitochondrial insertion during apoptosis. Apoptosis 12(5):887–896CrossRefPubMedGoogle Scholar
  22. Langlois A, Bietiger W, Mandes K, Maillard E, Belcourt A, Pinget M, Kessler L, Sigrist S (2008) Overexpression of vascular endothelial growth factor in vitro using deferoxamine: a new drug to increase islet vascularization during transplantation. Transpl Proc 40(2):473–476CrossRefGoogle Scholar
  23. Li H, Gu B, Zhang Y, Lewis DF, Wang Y (2005) Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 26(2–3):210–217CrossRefPubMedGoogle Scholar
  24. Li Q, Michaud M, Stewart W, Schwartz M, Madri JA (2008) Modeling the neurovascular niche: murine strain differences mimic the range of responses to chronic hypoxia in the premature newborn. J Neurosci Res 86(6):1227–1242CrossRefPubMedPubMedCentralGoogle Scholar
  25. Madri JA (2009) Modeling the neurovascular niche: implications for recovery from CNS injury. J Physiol Pharmacol 60(4):95–104PubMedGoogle Scholar
  26. Majumdar D, Bhonde R, Datta I (2013) Influence of ischemic microenvironment on human Wharton’s Jelly mesenchymal stromal cells. Placenta 34(8):642–649CrossRefPubMedGoogle Scholar
  27. Martens L, Kirschner K, Warnecke C, Scholz H (2006) Hypoxia stimulates expression of the trkbneurotrophin receptor in vitro and in vivo. Acta Physiologica 186 Suppl 650:OM02–12Google Scholar
  28. Martens LK, Kirschner KM, Warnecke C, Scholz H (2007) Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator of the TrkBneurotrophin receptor gene. J Biol Chem 282(19):14379–14388CrossRefPubMedGoogle Scholar
  29. Mazumdar J, O’Brien WT, Johnson RS, La Manna JC, Chavez JC, Klein PS, Simon MC (2010) Neuronal Hif-1α regulates neurogenesis through Wnt/β-catenin signaling. Nat Cell Biol 12(10):1007–1013CrossRefPubMedPubMedCentralGoogle Scholar
  30. Modo M, Stroemer RP, Tang E, Patel S, Hodges H (2003) Effects of implantation site of dead stem cells in rats with stroke damage. Neuroreport 14(1):39–42CrossRefPubMedGoogle Scholar
  31. Najafi R, Sharifi AM (2013) Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats. Expert Opin Biol Ther 13(7):959–972CrossRefPubMedGoogle Scholar
  32. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74(4):609–619CrossRefPubMedGoogle Scholar
  33. Pham I, Uchida T, Planes C, Ware LB, Kaner R, Matthay MA, Clerici C (2002) Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 283(5):L1133–L1142CrossRefPubMedGoogle Scholar
  34. Piret JP, Mottet D, Raes M, Michiels C (2002) Is HIF-1alpha a pro- or an anti-apoptotic protein? Biochem Pharmacol 64(5–6):889–892CrossRefPubMedGoogle Scholar
  35. Potier E, Ferreira E, Dennler S, Mauviel A, Oudina K, Logeart-Avramoglou D, Petite H (2008) Desferrioxamine-driven upregulation of angiogenic factor expression by human bone marrow stromal cells. J Tissue Eng Regen Med 2(5):272–278CrossRefPubMedGoogle Scholar
  36. Salehinejad P, Alitheen NB, Ali AM, Omar AR, Mohit M, Janzamin E, Samani FS, Torshizi Z, Nematollahi-Mahani SN (2012) Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton’s jelly, in vitro. Cell Dev Biol Animal 48:75–83CrossRefGoogle Scholar
  37. Salehinejad P, Alitheen N, Ali AM, Omar AR, Moshrefi M, Motamedi B, Nematollahi-mahani SN (2014) Neural differentiation of human umbilical cord matrix-derived mesenchymal cells under special culture conditions. Cytotechnology. doi: 10.1007/s10616-014-9703-6 PubMedPubMedCentralGoogle Scholar
  38. Scorrano L, Korsmeyer SJ (2013) Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 304(3):437–444CrossRefGoogle Scholar
  39. Sharifi AM, Mousavi SH, Jorjani M (2010) Effect of chronic lead exposure on pro-apoptotic Bax and anti-apoptotic Bcl-2 PROTEIN expression in rat hippocampus invivo. Cell Mol Neurobiol 30(5):769–774CrossRefPubMedGoogle Scholar
  40. Sortwell CE, Pitzer MR, Collier TJ (2000) Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival. Exp Neurol 165(2):268–277CrossRefPubMedGoogle Scholar
  41. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA (2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111(12):1843–1851CrossRefPubMedPubMedCentralGoogle Scholar
  42. Tavakol S, Aligholi H, Gorji A, Eshaghabadi A, Hoveizi E, Tavakol B, Rezayat SM, Ai J (2014) Thermogelnanofiber induces human endometrial-derived stromal cells to neural differentiation: in vitro and in vivo studies in rat. J Biomed Mater Res A 102(12):4590–4597PubMedGoogle Scholar
  43. Tavakol S, ModarresMousavi SM, Massumi M, Amani A, Rezayat SM, Ai J (2015) The effect of Noggin supplementation in Matrigel nanofiber-based cell culture system for derivation of neural-like cells from human endometrial-derived stromal cells. J Biomed Mater Res A 103(1):1–7CrossRefPubMedGoogle Scholar
  44. Tejado A-M, Naranjo-Suarez S, Jiménez C, Carrera AC, Landázuri MO, del Peso L (2001) Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J Biol Chem 276(25):22368–22374CrossRefGoogle Scholar
  45. Texel SJ, Zhang J, Camandola S, Unger EL, Taub DD, Koehler RC, Harris ZL, Mattson MP (2011) Ceruloplasmin deficiency reduces levels of iron and BDNF in the cortex and striatum of young mice and increases their vulnerability to stroke. PLoS One 6(9):e25077CrossRefPubMedPubMedCentralGoogle Scholar
  46. Tsai CY, Chan JY, Hsu KS, Chang AY, Chan SH (2012) Brain-derived neurotrophic factor ameliorates brain stem cardiovascular dysregulation during experimental temporal lobe status epilepticus. PLoS One 7(3):e33527CrossRefPubMedPubMedCentralGoogle Scholar
  47. Wang GL, Semenza GL (1993) Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82(12):3610–3615PubMedGoogle Scholar
  48. Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz JB (2002) Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 22(15):6401–6407PubMedGoogle Scholar
  49. Xiao H, Gu Z, Wang G, Zhao T (2013) The possible mechanisms underlying the impairment of HIF-1α pathway signaling in hyperglycemia and the beneficial effects of certain therapies. Int J Med Sci 10(10):1412–1421CrossRefPubMedPubMedCentralGoogle Scholar
  50. Yamakawa M, Liu LX, Date T, Belanger AJ, Vincent KA, Akita GY, Kuriyama T, Cheng SH, Gregory RJ, Jiang C (2003) Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 93(7):664–673CrossRefPubMedGoogle Scholar
  51. Zaman K, Ryu H, Hall D, O’Donovan K, Lin KI, Miller MP, Marquis JC, Baraban JM, Semenza GL, Ratan RR (1999) Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J Neurosci 19(22):9821–9830PubMedGoogle Scholar
  52. Zawada WM, Zastrow DJ, Clarkson ED, Adams FS, Bell KP, Freed CR (1998) Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res 786(1–2):96–103CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Fatemeh Nouri
    • 1
  • Parvin Salehinejad
    • 2
  • Seyed Noureddin Nematollahi-mahani
    • 2
  • Tunku Kamarul
    • 3
  • Mohammad Reza Zarrindast
    • 4
  • Ali Mohammad Sharifi
    • 1
    • 3
    • 5
    Email author
  1. 1.Razi Drug Research Center, Department of Pharmacology, School of MedicineIran University of Medical ScienceTehranIran
  2. 2.Department of Anatomy, Afzalipour School of MedicineKerman University of Medical SciencesKermanIran
  3. 3.Tissue Engineering Group (TEG) and Research, National Orthopedic Centre of Excellence in Research and Learning (NOCERAL), Department of Orthopedics, Faculty of MedicineUniversity of MalayaKuala LumpurMalaysia
  4. 4.Department of Neuroscience, School of Advanced Technologies in MedicineTehran University of Medical SciencesTehranIran
  5. 5.Department of Tissue Engineering and Regenerative Medicine, School of Advanced Technologies in MedicineIran University of Medical SciencesTehranIran

Personalised recommendations